Home › Pancreatitis › Illinois › Chicago
Pancreatitis clinical trials in Chicago, IL
4 studies for Pancreatitis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
RecruitingPhase 2
- UI Health, University of Illinois Chicago Hospital Health Sciences System, Chicago
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics
RecruitingObservational study
- Northwestern University, Chicago
- University of Illinois at Chicago, Chicago
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
RecruitingObservational study
- Northwestern University, Chicago
- University of Illinois at Chicago, Chicago
iMmune SignAtures and Clinical outComes in AP
RecruitingObservational study
- University of Illinois Chicago, Chicago
About Pancreatitis
Pancreatitis is inflammation of the pancreas. Pancreatitis can be acute or chronic. Learn about pancreatitis symptoms and treatment.
More about Pancreatitis on MedlinePlus
Pancreatitis trials in other cities
- Pittsburgh, PA9 studies
- Baltimore, MD8 studies
- Los Angeles, CA7 studies
- Columbus, OH6 studies
- Indianapolis, IN5 studies
- Minneapolis, MN4 studies
- Seattle, WA4 studies
- Orlando, FL4 studies
- Boston, MA4 studies
- Mountain View, CA4 studies
- Rochester, MN3 studies
- Gainesville, FL3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.